A5005890361- Vasculitis and related conditions
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Systemic Sclerosis and Related Diseases
- Eosinophilic Disorders and Syndromes
- Sarcoidosis and Beryllium Toxicity Research
- Systemic Lupus Erythematosus Research
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Urticaria and Related Conditions
- Otitis Media and Relapsing Polychondritis
- Renal Diseases and Glomerulopathies
- Inflammatory Myopathies and Dermatomyositis
- Rheumatoid Arthritis Research and Therapies
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Autoimmune and Inflammatory Disorders Research
- Eosinophilic Esophagitis
- Musculoskeletal pain and rehabilitation
- Gastrointestinal disorders and treatments
- Inflammasome and immune disorders
- Coronary Artery Anomalies
- Kawasaki Disease and Coronary Complications
- Autoimmune Bullous Skin Diseases
- Retinal and Optic Conditions
- Renal and Vascular Pathologies
- Amyloidosis: Diagnosis, Treatment, Outcomes
Mayo Clinic in Florida
2015-2024
Jacksonville College
2015-2024
WinnMed
2015-2024
Mayo Clinic in Arizona
2016-2024
Universidad de Antioquia
2024
Mayo Clinic
1998-2024
Center for Rheumatology
2017-2023
RELX Group (United States)
2023
American College of Rheumatology
2021
Columbia University Irving Medical Center
2021
The objective of this study was to develop EULAR/ACR classification criteria for polymyalgia rheumatica (PMR). Candidate were evaluated in a 6-month prospective cohort 125 patients with new onset PMR and 169 non-PMR comparison subjects conditions mimicking PMR. A scoring algorithm developed based on morning stiffness >45 minutes (2 points), hip pain/limited range motion (1 point), absence RF and/or ACPA peripheral joint pain point). score ≥4 had 68% sensitivity 78% specificity discriminating...
Abstract The objective of this study was to develop European League Against Rheumatism/American College Rheumatology classification criteria for polymyalgia rheumatica (PMR). Candidate were evaluated in a 6‐month prospective cohort 125 patients with new‐onset PMR and 169 non‐PMR comparison subjects conditions mimicking PMR. A scoring algorithm developed based on morning stiffness >45 minutes (2 points), hip pain/limited range motion (1 point), absence rheumatoid factor and/or...
Abstract Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) management PMR. We used Grading Recommendations, Assessment, Development and Evaluation (GRADE) methodology a framework project. Accordingly, direction strength based on quality evidence, balance between desirable...
Therapy for polymyalgia rheumatica (PMR) varies widely in clinical practice as international recommendations PMR treatment are not currently available. In this paper, we report the 2015 European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) management PMR. We used Grading Recommendations, Assessment, Development and Evaluation (GRADE) methodology a framework project. Accordingly, direction strength based on quality evidence, balance between desirable undesirable...
Objective To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists. Methods Sixteen questions regarding diagnostic testing, treatment, KD were developed in Patient/Population, Intervention, Comparison, Outcomes (PICO) question format. Systematic literature reviews conducted each PICO question. We used Grading Recommendations, Assessment, Development Evaluation method to...
Objective Avacopan, an activated complement factor 5 receptor antagonist, has been approved as adjunct therapy for severe active antineutrophil cytoplasmic antibody–associated vasculitis (AAV). Current evidence supports the management of AAV presenting with diffuse alveolar hemorrhage (DAH) by administering glucocorticoids combined either rituximab or cyclophosphamide in addition to supportive care. The role avacopan patients DAH a primary disease manifestation not well established....
Eosinophilic Fasciitis: Spectrum of MRI FindingsStacy J. Moulton1, Mark Kransdorf1, William W. Ginsburg2, Andy Abril2 and Scott Persellin2Audio Available | Share
Objective. To prospectively evaluate the disease course and performance of clinical, patient-reported outcome (PRO) musculoskeletal ultrasound measures in patients with polymyalgia rheumatica (PMR). Methods. The study population included 85 new-onset PMR who were initially treated prednisone equivalent dose 15 mg daily tapered gradually, followed for 26 weeks. Data collection physical examination findings, laboratory acute-phase reactants, PRO measures. Ultrasound evaluation was performed at...
To evaluate factors associated with mortality and infections in patients systemic lupus erythematosus (SLE) diffuse alveolar hemorrhage (DAH).A retrospective chart review was carried out for medical admissions of a diagnosis SLE DAH 9 hospitals. Clinical laboratory data were recorded each patient at diagnosis.We included 57 episodes 50 (7 recurrences), 49 women (86%), 14 juvenile (24.6%); 24 had died (42.1%). In the we detected infection 22 (38.6%): 8 invasive fungal infections, 16 bacterial...
Objective To provide evidence‐based recommendations and expert guidance for the management of Kawasaki disease (KD), focusing on clinical scenarios more commonly addressed by rheumatologists. Methods Sixteen questions regarding diagnostic testing, treatment, KD were developed in Patient/Population, Intervention, Comparison, Outcomes (PICO) question format. Systematic literature reviews conducted each PICO question. We used Grading Recommendations, Assessment, Development Evaluation method to...
Objective To evaluate the safety and efficacy of tocilizumab (TCZ) in giant cell arteritis (GCA) a large North American cohort. Methods Patients with GCA treated TCZ between January 1, 2010, May 15, 2020, were retrospectively identified. Kaplan-Meier methods used to estimate time discontinuation first relapse after discontinuation. Poisson regression models compare annualized rates before, during, use. Age- sex-adjusted risk factors associated on off development adverse events significant...
To describe our experience with 16 patients eosinophilic fasciitis (EF) treated in clinic over 14 years.We retrospectively reviewed the charts of all biopsy-proven EF. We collected data regarding demographics, clinical presentations, possible triggers, labs, imaging, treatment and response to therapy on follow-up.Eight women eight men a mean age 52 years were included study. Three related onset prior strenuous exercise one was exposed vibratory machinery. Fourteen had gradual presented...